At the beginning of the pandemic, remote retinal imaging declined sharply due to a recommendation to stop nonessential eye care services in the first months of 2020, said Parisa Emami-Naeni, MD, MPH, assistant professor of ophthalmology at University of California, Davis, and vitreoretinal surgeon and uveitis specialist at UC Davis Eye Center.
At the beginning of the pandemic, remote retinal imaging declined sharply due to a recommendation to stop nonessential eye care services in the first months of 2020, said Parisa Emami-Naeni, MD, MPH, assistant professor of ophthalmology at University of California, Davis, and vitreoretinal surgeon and uveitis specialist at UC Davis Eye Center.
Transcript
Use of remote retinal imaging initially declined sharply during the first months of the pandemic in 2020. What do you attribute this initial decline to when adoption of virtual or video visits increased overall in the early months of the pandemic?
So, in our study, we looked at the administrative claims data on individuals with private insurance or Medicare Advantage plans between early 2020—January 2020—until the end of 2020. And, as you mentioned, we found that the use of remote eye imaging declined sharply at the beginning of the pandemic—in the months of March and April 2020—with about a 60% decline in the number of the insurance claims for teleophthalmology.
However, in the latter half of 2020, the incidence of the claims increased back to the prepandemic levels. We think that the initial decline is most likely related to the initial period of the COVID-19 lockdowns and the American Academy of Ophthalmology recommendations to stop nonessential eye care services at that time. Also, the uncertainty of the situation at the beginning of the pandemic was likely contributing to this.
Changes that were made to reimbursements of televisits and teleophthalmology by [CMS] later on encouraged the use of these services later in the year. So, the numbers went back up.
FIT Completion, Yield Rates in CRC Screening Similar After New Screening Guidelines
October 22nd 2024Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and 50 years, making screening for colorectal cancer (CRC) effective in younger patients.
Read More
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
October 22nd 2024This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More